share_log

MBX Biosciences | SC 13D: Statement of acquisition of beneficial ownership by individuals-OrbiMed Advisors LLC(12.0%),OrbiMed Capital GP VII LLC(9.9%), etc.

MBX Biosciences | SC 13D:超过5%持股股东披露文件-OrbiMed Advisors LLC(12.0%),OrbiMed Capital GP VII LLC(9.9%)等

美股SEC公告 ·  09/23 16:38
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息